Study Focus: This study looks at how safe and effective a treatment called Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) is for pancreatic lesions. Pancreatic lesions are areas of abnormal tissue in the pancreas, which can be pre-cancerous or cancerous.
What to Know:
- This study lasts for 7 years and is conducted at a single center.
- Participants must already be receiving the EUS-RFA treatment for their pancreatic lesions.
- People with other types of cancer or who cannot give consent or complete follow-up are not eligible.
Key Details:
- This study is a long-term commitment, lasting 7 years.
- Participants should be prepared for regular follow-ups.
- It aims to ensure the treatment is both safe and effective for patients.
How understandable was the trial content above?
Hard to understand
Easy to understand